Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Notice of Interim Results

15 Aug 2022 07:00

RNS Number : 9106V
Spire Healthcare Group PLC
15 August 2022
 

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Notice of Interim Results

 

15 August 2022

 

Spire Healthcare Group plc (LSE: SPI), a leading independent hospital group in the UK, will announce its interim results for the six months ended 30 June 2022 on Thursday 8 September 2022.

 

A Zoom webcast presentation for sell-side analysts and investors will be held at 9.00am BST on 8 September. If you wish to attend the webinar, please register in advance at https://spirehealthcare.zoom.us/webinar/register/WN_7PsBnqaqTPmJy0j2dI-PMA

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

 

 

Angus Prentice - Interim Head of Investor Relations

+44 (0)7974 982 512

 

 

 

Instinctif Partners

 

Damian Reece

+44 (0)7931 598 593

Guy Scarborough

 

+44 (0)7917 178 920

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and eight clinics across England, Wales and Scotland.

 

Working in partnership with around 8,150 experienced Consultants, Spire Healthcare delivered tailored, personalised care to almost 870,000 in-patients and daycase patients in 2021, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

 

The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers.

 

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORZLLFFLVLFBBB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.